NCT00479713
A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)
See it on ClinicalTrials.gov ↗618 people
40.1%
59.9%
248 womenmiddle line = equal numbers370 men
- Phase
- PHASE3
- Paid for by
- Organon and Co
- Finished
- 2008-03-01
- Health conditions
- Hypercholesterolemia
- Who could join
- Anyone
- Ages
- 18 Years – 79 Years
- Average age
- mean 63.15 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 99.7% · Black / African American 0.3%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Women who are pregnant or nursing, or women who intend to become pregnant”
Study titles and rules are shown in their original English.